Squarepoint Ops LLC Idera Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$1.06 - $2.15 $10,689 - $21,680	-10,084 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.45 - $2.79 $3,668 - $7,058	-2,530 Reduced 20.06%	10,084 $18,000
Q3 2019 Nov 14, 2019	SELL	$2.12 - $3.31 $5,965 - $9,314	-2,814 Reduced 18.24%	12,614 $36,000
Q2 2019 Aug 14, 2019	BUY	$2.37 - $3.97 $36,564 - $61,249	15,428 New	15,428 $41,000
Q1 2019 May 15, 2019	SELL	$2.33 - $3.79 $44,037 - $71,631	-18,900 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.77 - $9.38 $16,370 - $55,435	5,910 Added 45.5%	18,900 $52,000
Q3 2018 Nov 14, 2018	BUY	$5.53 - $11.36 $71,834 - $147,566	12,990 New	12,990 $116,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.